|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1201 Maryland Avenue SW |
Address2 | Suite 900 |
City | Washington |
State | DC |
Zip Code | 20024 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 6245-12
|
||||||||
|
6. House ID# 325050000
|
TYPE OF REPORT | 8. Year | 2014 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Brent DelMonte, Vice President for Federal Government Relations |
Date | 04/21/2014 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AGR
16. Specific lobbying issues
Review and Labeling of Food Derived From Biotechnology
House Energy and Commerce Discussion Draft
U.S. Government Policy
EPA Regulations on Agricultural Biotechnology
Efficient Science-Based Review of Biotech Products
Herbicide Label Changes
Insect Resistance Management
Department of Interior, Environment, and Related Agencies Appropriations Act for FY 2015
Genetically Engineered (GE) Animals
Labeling
Agriculture, Rural Development, FDA, and Related Appropriations Act for 2015
FDA Approval
H.R. 3547: Consolidated Appropriations Act for FY 2014
Funding for USDA
H.R. 3547: Consolidated Appropriations Act for FY 2014
Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY
2015
Foreign Agricultural Biotechnology Laws and Regulations
Asynchrony of International Approvals
China Biotechnology Regulations
Korea Biotechnology Regulations
Funding for Biotechnology Research and Development Programs at the Agency for International Development and Department of State
H.R. 3547: Consolidated Appropriations Act for FY 2014
Biomass Programs
Reauthorization of Biomass Crop Assistance Program
Reauthorization of Biomass R&D Program
S.954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
H.R. 2642: Agricultural Act of 2014 (Farm Bill)
Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015
USDA/APHIS Agricultural Biotechnology Regulations
Efficient Science-Based Review of Biotech Products
USDA Decision on GE Crops Environmental Impact Statement
Coexistence of Production Systems
Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015
Trans Pacific Partnership
Sanitary and Phytosanitary Issues
Transatlantic Trade and Investment Partnership
Ag-Biotech Issues
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Environmental Protection Agency (EPA), U.S. Trade Representative (USTR)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cathleen |
Enright |
|
|
|
David |
Edwards |
|
|
|
Tracey |
LaTurner |
|
|
|
Dana |
O'Brien |
|
|
|
Matthew |
Carr |
|
|
|
Brent |
Del Monte |
|
|
|
Erick |
Lutt |
|
|
|
Matthew |
O'Mara |
|
|
|
Anna |
Weinstein |
|
|
|
Tom |
Dilenge |
|
|
|
Derrick |
White |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ANI
16. Specific lobbying issues
Genetically Engineered (GE) Animals
Labeling
Agriculture, Rural Development, FDA, and Related Appropriations Act for FY 2015
FDA Approval
Genetically Engineered (GE) Animals Cont...
H.R. 3547: Consolidated Appropriations Act for FY 2014
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tracey |
LaTurner |
|
|
|
Dana |
O'Brien |
|
|
|
David |
Edwards |
|
|
|
Brent |
DelMonte |
|
|
|
Anna |
Weinstein |
|
|
|
Cathleen |
Enright |
|
|
|
Derrick |
White |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Funding for FDA
Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015
H.R. 3547: Consolidated Appropriations Act for FY 2014
Funding for USDA
H.R. 3547: Consolidated Appropriations Act for FY 2014
Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015
H.R. 3547: Consolidated Appropriations Act for FY 2014
Funding for Centers for Disease Control and Prevention Vaccine Programs
Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015
H.R. 3547: Consolidated Appropriations Act for FY 2014
Funding for National Institutes of Health
Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015
H.R. 3547: Consolidated Appropriations Act for FY 2014
Funding for Biomass Crop Assistance Program
Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015
Sequestration of PDUFA Fees
HR 2725: Food and Drug Administration Safety over Sequestration Act of 2013
S. 1413: FDA User Fee Protection Act
H.R. 3547: Consolidated Appropriations Act for FY 2014
Energy Basic Research Funding
Energy and Water Development and Related Agencies Appropriations Act for FY 2015
H.R. 3547: Consolidated Appropriations Act for FY 2014
Funding for Renewable Chemicals/Bio-based Products
Energy and Water Development and Related Agencies Appropriations Act for FY 2015
Funding for Biofuels
Department of Defense Funding of Advanced Biofuels
Energy and Water Development and Related Agencies Appropriations Act for FY 2015
Department of Defense Appropriations Act for FY 2015
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
H.R. 2642: Agricultural Act of 2014 (Farm Bill)
Agriculture, Rural Development, FDA, and Related Agencies Appropriations for FY 2015
Department of the Interior, Environment, and Related Agencies Appropriations for FY 2015
H.R. 3547: Consolidated Appropriations Act for FY 2014
Funding for Biorefineries
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
H.R. 2642: Agricultural Act of 2014 (Farm Bill)
Funding for Biotechnology Research and Development Programs and the Agency for International Development and Department of State
H.R. 3547: Consolidated Appropriations Act for FY 2014
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Natl Security Council (NSC), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tracey |
LaTurner |
|
|
|
Matthew |
Carr |
|
|
|
Anna |
Weinstein |
|
|
|
Andrew |
Emmett |
|
|
|
David |
Edwards |
|
|
|
Brent |
DelMonte |
|
|
|
Derrick |
White |
|
|
|
Sara |
Radcliffe |
|
|
|
Jeanne |
Haggerty |
|
|
|
Kelly |
Cappio |
|
|
|
Erick |
Lutt |
|
|
|
Phyllis |
Arthur |
|
|
|
Matthew |
Schumaker |
|
|
|
Dana |
O'Brien |
|
|
|
Catharine |
Harris |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
Genetic Resource Patent Disclosure Requirement
World Intellectual Property Organization
Patent Reform
S. 866: Patent Quality Improvement Act of 2013
S. 1720: Patent Transparency and Improvements Act of 2013
H.R. 3309: The Innovation Act of 2013
S. 1013: Patent Abuse Reduction Act of 2013
FTC Regulation of Patent Demand Letters (Senator McCaskill Discussion Draft)
World Trade Organization Special 301 Submissions
Intellectual Property International Enforcement
Compulsory Licensing
TransPacific Partnership
Data and Intellectual Property Protections for Pharmaceuticals
Transatlantic Trade and Investment Partnership
Intellectual Property Issues
Drug Repurposing
H.R. 4287/2150: Independent Innovator and Repurposing Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Patent & Trademark Office (PTO), U.S. Trade Representative (USTR)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Schumaker |
|
|
|
Hans |
Sauer |
|
|
|
Jeanne |
Haggerty |
|
|
|
Brent |
Del Monte |
|
|
|
Tom |
DiLenge |
|
|
|
Joseph |
Damond |
|
|
|
Charles |
Fritts |
|
|
|
Anna |
Weinstein |
|
|
|
Derrick |
White |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CSP
16. Specific lobbying issues
Funding for FDA
Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015
H.R. 3547: Consolidated Appropriations Act for FY 2014
Genetically Engineered (GE) Animals
Labeling
Agriculture, Rural Development, FDA, and Related Appropriations Act for FY 2015
FDA Approval
H.R. 3547: Consolidated Appropriations Act for FY 2014
Review and Labeling of Food Derived From Biotechnology
House Energy and Commerce Discussion Draft
U.S. Government Policy
Drug Evaluation and Review
Special Medical Use/Limited Population Drug
Implementation of the FDA Safety and Innovation Act
H.R. 3742: Antibiotic Development to Advance Patient Treatment Act of 2013
FDA Proposed Rule on Changes to Drug Labeling
Biosimilars
Naming
Biosimilar User Fee Act Implementation
Interchangeability and Pharmacy Substitution
Colombia Biologics Regulations
Drug Manufacturing, Quality & Distribution
Implementation of H.R. 3204: The Drug Quality and Security Act
USDA/APHIS Agricultural Biotechnology Regulations
Efficient Science-Based Review of Biotech Products
USDA Decision on GE Crops Environmental Impact Statement
Coexistence of Production Systems
Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015
Sunshine Act Implementation
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Federal Trade Commission (FTC), Food & Drug Administration (FDA), U.S. Trade Representative (USTR)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cathleen |
Enright |
|
|
|
David |
Edwards |
|
|
|
Andrew |
Emmett |
|
|
|
Anna |
Weinstein |
|
|
|
Sara |
Radcliffe |
|
|
|
Jeanne |
Haggerty |
|
|
|
Derrick |
White |
|
|
|
Dana |
O'Brien |
|
|
|
Matthew |
Schumaker |
|
|
|
Tom |
DiLenge |
|
|
|
Brent |
DelMonte |
|
|
|
Matthew |
O'Mara |
|
|
|
Cartier |
Esham |
|
|
|
Tracey |
LaTurner |
|
|
|
Jeffrey |
Peters |
|
|
|
. |
. |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENG
16. Specific lobbying issues
Funding for Biomass Crop Assistance Program
Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015
Biofuels
Accelerated Depreciation Extension
Production Tax Credit Extension
Renewable Fuel Standard
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 2642: Agricultural Act of 2014 (Farm Bill)
Biorefineries
Reauthorization of Biorefinery Assistance Program
HR 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 2642: Agricultural Act of 2014 (Farm Bill)
Renewable Chemicals/Bio-based Products
New Production Tax Credit for Renewable Chemicals
Reauthorization of USDA Bio-Preferred Program
Bonus Depreciation for Renewable Chemical Facilities
S. 1267/H.R. 3084: Renewable Chemical Production Tax Credit Act
H.R. 2642: Agricultural Act of 2014 (Farm Bill)
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
Biomass Programs
Reauthorization of Biomass R&D Program
Reauthorization of Biomass Crop Assistance Program
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S.954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 2642: Agricultural Act of 2014 (Farm Bill)
Energy Basic Research Funding
H.R. 3547: Consolidated Appropriations Act for FY 2014
Energy and Water Development and Related Agencies Appropriations Act for FY 2015
Funding for Renewable Chemicals/Bio-based Products
Energy and Water Development and Related Agencies Appropriations Act for FY 2015
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S.954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 2642: Agricultural Act of 2014 (Farm Bill)
Funding for Biofuels
Department of Defense Funding of Advanced Biofuels
Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015
Energy and Water Development and Related Agencies Appropriations Act for FY 2015
Department of Defense Appropriations Act for FY 2015
Department of the Interior, Environment, and Related Agencies Appropriations for FY 2015
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
H.R. 3547: Consolidated Appropriations Act for FY 2014
H.R. 2642: Agricultural Act of 2014 (Farm Bill)
Funding for Biorefineries
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
H.R. 2642: Agricultural Act of 2014 (Farm Bill)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Carr |
|
|
|
Dana |
O'Brien |
|
|
|
Tracey |
LaTurner |
|
|
|
Charles |
Fritts |
|
|
|
Rina |
Singh |
|
|
|
Brent |
Del Monte |
|
|
|
Erick |
Lutt |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOO
16. Specific lobbying issues
Review and Labeling of Food Derived From Biotechnology
House Energy and Commerce Discussion Draft
U.S. Government Policy
Genetically Engineered (GE) Animals
Labeling
Agriculture, Rural Development, FDA, and Related Appropriations Act for FY 2015
FDA Approval
H.R. 3547: Consolidated Appropriations Act for FY 2014
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cathleen |
Enright |
|
|
|
David |
Edwards |
|
|
|
Dana |
O'Brien |
|
|
|
Tracey |
LaTurner |
|
|
|
Brent |
Del Monte |
|
|
|
Anna |
Weinstein |
|
|
|
Tom |
DiLenge |
|
|
|
Matthew |
O'Mara |
|
|
|
Derrick |
White |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FUE
16. Specific lobbying issues
Funding for Biomass Crop Assistance Program
Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015
Biofuels
Accelerated Depreciation Extension
Production Tax Credit Extension
Renewable Fuel Standard
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 2642: Agricultural Act of 2014 (Farm Bill)
Biorefineries
Reauthorization of Biorefinery Assistance Program
HR 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 2642: Agricultural Act of 2014 (Farm Bill)
Renewable Chemicals/Bio-based Products
New Production Tax Credit for Renewable Chemicals
Reauthorization of USDA Bio-Preferred Program
Bonus Depreciation for Renewable Chemical Facilities
S. 1267/H.R. 3084: Renewable Chemical Production Tax Credit Act
H.R. 2642: Agricultural Act of 2014 (Farm Bill)
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
Biomass Programs
Reauthorization of Biomass R&D Program
Reauthorization of Biomass Crop Assistance Program
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S.954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 2642: Agricultural Act of 2014 (Farm Bill)
Energy Basic Research Funding
H.R. 3547: Consolidated Appropriations Act for FY 2014
Energy and Water Development and Related Agencies Appropriations Act for FY 2015
Funding for Renewable Chemicals/Bio-based Products
Energy and Water Development and Related Agencies Appropriations Act for FY 2015
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S.954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 2642: Agricultural Act of 2014 (Farm Bill)
Funding for Biofuels
Department of Defense Funding of Advanced Biofuels
Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015
Energy and Water Development and Related Agencies Appropriations Act for FY 2015
Department of Defense Appropriations Act for FY 2015
Department of the Interior, Environment, and Related Agencies Appropriations for FY 2015
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
H.R. 3547: Consolidated Appropriations Act for FY 2014
H.R. 2642: Agricultural Act of 2014 (Farm Bill)
Funding for Biorefineries
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
H.R. 2642: Agricultural Act of 2014 (Farm Bill)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Carr |
|
|
|
Dana |
O'Brien |
|
|
|
Tracey |
LaTurner |
|
|
|
Charles |
Fritts |
|
|
|
Rina |
Singh |
|
|
|
Brent |
DelMonte |
|
|
|
Erick |
Lutt |
|
|
|
. |
. |
|
|
|
. |
. |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Funding for National Institutes of Health
Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015
H.R. 3547: Consolidated Appropriations Act for FY 2014
Biosimilars
Naming
Biosimilar User Fee Act Implementation
Interchangeability and Pharmacy Substitution
Colombia Biologics Regulations
Funding for Centers for Disease Control and Prevention Vaccine Programs
Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015
H.R. 3547: Consolidated Appropriations Act for FY 2014
Vaccine Access/Financing
Vaccine Injury Compensation Program
Adult Immunization (Senate Discussion Draft)
340B Drug Pricing Program
Program Implementation & Oversight
Implementation of Affordable Care Act
Department of Labor, HHS, Education and Related Agencies Appropriations Act for FY 2015
H.R. 3547: Consolidated Appropriations Act for FY 2014
Funding for FDA
Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015
H.R. 3547: Consolidated Appropriations Act for FY 2014
Independent Payment Advisory Board
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015
H.R. 3547: Consolidated Appropriations Act for FY 2014
Reimbursement for Innovative Products
Medicare Part D Prescription Drug Program
CMS Proposed Rule on Protected Classes
Medicare Part B Physician-Administered Products
H.R. 1416: Cancer Patient Protection Act of 2013
National Center for Advancing Translational Science (NCATS)
Program Implementation
Sequestration of PDUFA Fees
HR 2725: Food and Drug Administration Safety over Sequestration Act of 2013
S. 1413: FDA User Fee Protection Act
H.R. 3547: Consolidated Appropriations Act for FY 2014
Drug Repurposing
H.R. 4287/2150: Independent Innovator and Repurposing Act
Transatlantic Trade and Investment Partnership
Reimbursement Transparency
Intellectual Property Issues
Regulatory Harmonization
TransPacific Partnership
Data and Intellectual Property Protections for Pharmaceuticals
Regulatory Transparency
Drug Evaluation and Review
Special Medical Use/Limited Population Drug
H.R. 3742: Antibiotic Development to Advance Patient Treatment Act of 2013
Implementation of the FDA Safety and Innovation Act
FDA Proposed Rule on Changes to Drug Labeling
Orphan Drug Act Tax Credit
Drug Manufacturing, Quality & Distribution
Implementation of H.R. 3204: The Drug Quality and Security Act
Sunshine Act Implementation
Medicare Physician Payment Sustainable Growth Rate Formula
HR 4302: Protecting Access to Medicare Act of 2014
S. 2110: Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014
S. 2000: SGR Repeal and Medicare Provider Payment Modernization Act of 2014
S. 2122: Responsible Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014
Clinical Trial Data Sharing and Disclosure
EU Policies
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Federal Trade Commission (FTC), Food & Drug Administration (FDA), Natl Institutes of Health (NIH), Natl Security Council (NSC), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), U.S. Trade Representative (USTR)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Catharine |
Harris |
|
|
|
Andrew |
Emmett |
|
|
|
Charles |
Fritts |
|
|
|
Matthew |
Schumaker |
|
|
|
Jeanne |
Haggerty |
|
|
|
Sara |
Radcliffe |
|
|
|
Phyllis |
Arthur |
|
|
|
Anna |
Weinstein |
|
|
|
Derrick |
White |
|
|
|
Tom |
DiLenge |
|
|
|
Tracey |
LaTurner |
|
|
|
Laurel |
Todd |
|
|
|
Kelly |
Cappio |
|
|
|
Brent |
DelMonte |
|
|
|
Cartier |
Esham |
|
|
|
Jeffrey |
Peters |
|
|
|
Charles |
Crain |
|
|
|
Shelly |
Mui-Lipnik |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HOM
16. Specific lobbying issues
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015
H.R. 3547: Consolidated Appropriations Act for FY 2014
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Natl Security Council (NSC), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sara |
Radcliffe |
|
|
|
Phyllis |
Arthur |
|
|
|
Tracey |
LaTurner |
|
|
|
Kelly |
Cappio |
|
|
|
Brent |
DelMonte |
|
|
|
Anna |
Weinstein |
|
|
|
Derrick |
White |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Funding for National Institutes of Health
Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015
H.R. 3547: Consolidated Appropriations Act for FY 2014
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015
H.R. 3547: Consolidated Appropriations Act for FY 2014
National Center for Advancing Translational Science (NCATS)
Program Implementation
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Natl Institutes of Health (NIH), Natl Security Council (NSC), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sara |
Radcliffe |
|
|
|
Cartier |
Esham |
|
|
|
Kelly |
Cappio |
|
|
|
Phyllis |
Arthur |
|
|
|
Tracey |
LaTurner |
|
|
|
Brent |
DelMonte |
|
|
|
Anna |
Weinstein |
|
|
|
Derrick |
White |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Independent Payment Advisory Board
Reimbursement for Innovative Products
Medicare Part D Prescription Drug Program
CMS Proposed Rule on Protected Classes
Medicare Part B Physician-Administered Products
H.R. 1416: Cancer Patient Protection Act of 2013
Medicare Physician Payment Sustainable Growth Rate Formula
HR 4302: Protecting Access to Medicare Act of 2014
S. 2110: Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014
S. 2000: SGR Repeal and Medicare Provider Payment Modernization Act of 2014
S. 2122: Responsible Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Brent |
DelMonte |
|
|
|
Laurel |
Todd |
|
|
|
Matthew |
Schumaker |
|
|
|
Jeanne |
Haggerty |
|
|
|
Catharine |
Harris |
|
|
|
Anna |
Weinstein |
|
|
|
Derrick |
White |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SMB
16. Specific lobbying issues
Capital Market Enhancements
H.R. 3623: Improving Access to Capital for Emerging Growth Companies Act
Sarbanes Oxley Section 404 (b)
Mandatory Audit Firm Rotation
H.R. 1564/S. 1526: The Audit Integrity and Job Protection Act
Capital Formation Investment Incentives
Reform of Passive Loss Rules
Reform of Net Operating Loss Rules
Reform of Capital Gains Rules
S. 1658: The Start-up Jobs and Innovation Act
Reform of SEC Regulation D
Implementation of Jumpstart Our Business Start-ups (JOBS) Act
Legislative Amendments to SEC Rule 12b-2 Filing Status Definitions
H.R. 2629: The Fostering Innovation Act
XBRL Exemption for Small Public Companies
H.R. 4164: Small Company Disclosure Simplification Act
Stock Exchange Tick Size
H.R. 3488: The Small Cap Liquidity Reform Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Securities & Exchange Commission (SEC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Charles |
Crain |
|
|
|
Charles |
Fritts |
|
|
|
Shelly |
Mui-Lipnik |
|
|
|
Brent |
DelMonte |
|
|
|
Cartier |
Esham |
|
|
|
Tom |
DiLenge |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Biofuels
Accelerated Depreciation Extension
Production Tax Credit Extension
Renewable Chemicals/Bio-based Products
New Production Tax Credit for Renewable Chemicals
S. 1267/H.R. 3084: Renewable Chemical Production Tax Credit Act
Bonus Depreciation for Renewable Chemical Facilities
Research & Development Tax Credit Reforms
Extension
Permanency
The Start-up Innovation Credit Act (Senator Coons Discussion Draft)
The Innovative Research and Competitiveness Act (Senator Carper Discussion Draft)
Capital Formation Investment Incentives
Reform of Passive Loss Rules
Reform of Net Operating Loss Rules
Reform of Capital Gains Rules
S. 1658: The Start-up Jobs and Innovation Act
House Ways and Means Committee Discussion Draft (Rep. Camp)
Tax Reform
House Ways and Means Committee Discussion Draft (Rep. Camp)
Orphan Drug Act Tax Credit
Controlled Foreign Corporation Look-Through Rule Extension
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Carr |
|
|
|
Erick |
Lutt |
|
|
|
Shelly |
Mui-Lipnik |
|
|
|
Tom |
DiLenge |
|
|
|
Rina |
Singh |
|
|
|
Charles |
Fritts |
|
|
|
Charles |
Crain |
|
|
|
Brent |
Del Monte |
|
|
|
Matthew |
Schumaker |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRD
16. Specific lobbying issues
Trade Promotion Authority
H.R. 3830/S. 1900: Bipartisan Congressional Trade Priorities Act of 2014
Intellectual Property International Enforcement
Compulsory Licensing
Foreign Agricultural Biotechnology Laws and Regulations
Asynchrony of International Approvals
China Biotechnology Regulations
Korea Biotechnology Regulations
Genetic Resource Patent Disclosure Requirement
World Intellectual Property Organization
TransPacific Partnership
Data and Intellectual Property Protections for Pharmaceuticals
Regulatory Transparency
Sanitary and Phytosanitary Issues
Transatlantic Trade and Investment Partnership
Intellectual Property Issues
Regulatory Harmonization
Ag-Biotech Issues
Reimbursement Transparency
Biosimilars
Colombia Biologics Regulations
World Trade Organization Special 301 Submissions
Clinical Trial Data Sharing and Disclosure
EU Policies
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), U.S. Trade Representative (USTR)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tom |
DiLenge |
|
|
|
Andrew |
Emmett |
|
|
|
Brent |
DelMonte |
|
|
|
Joseph |
Damond |
|
|
|
Jeanne |
Haggerty |
|
|
|
Charles |
Fritts |
|
|
|
Matthew |
O'Mara |
|
|
|
Dana |
O'Brien |
|
|
|
Anna |
Weinstein |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address: BIO maintains a list of all of its members on its website at http://bio.org/membership/index.asp
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |